NCT06231849

Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 52 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: Male
• Age: 20 Years – 35 Years
• Healthy volunteers: Not accepted

Summary

This study will aim to investigate the gut microbiota in Egyptian patients with opioid use disorders and correlate microbiota bacterial abundance with clinical data.

Detailed description

Addiction is defined as a chronic, relapsing disorder characterized by compulsive drug seeking and use despite adverse consequences. Pathological substance use disorders represent a major public health crisis with limited effective treatment options. Although the gut and brain are separate organs, they communicate with each other via trillions of intestinal bacteria that collectively make up one's gut microbiome. Findings from both humans and animals support a critical role of gut microbes in regulating brain function, mood, and behavior. Gut bacteria influence neural circuits that are notably affected in addiction-related behaviors. These include circuits involved in stress, reward, and motivation, with substance use influencing gut microbial abnormalities, suggesting significant gut-brain interactions in drug addiction. The investigator will discuss this role of gut microbiome in Assuit university hospital to see how the pathogenesis can be altered of drug addiction.

Conditions

• Opioid Use
• Opioid Use Disorder
• Opioid Dependence

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	stool analysis	stool analysis to determine number of gut microbiota in subjects with opioid use and its effect on its intoxication.

Timeline

• Start date: 2024-02-01
• Primary completion: 2026-02-01
• Completion: 2026-04-01
• First posted: 2024-01-30
• Last updated: 2024-01-30